Michael J. Feldman

Michael J. Feldman's AcademicInfluence.com Rankings

Michael J. Feldman

Biology

#9816

World Rank

#13064

Historical Rank

Virology

#229

World Rank

#236

Historical Rank

Microbiology

#542

World Rank

#605

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Michael J. Feldman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael J. Feldman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. (1986) (508)
Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection (1985) (410)
HTLV-III in cells cultured from semen of two patients with AIDS. (1984) (314)
Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. (1992) (250)
C-C chemokines, pivotal in protection against HIV type 1 infection. (1998) (226)
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. (1998) (208)
The role of macrophages in the induction of antibody in x-irradiated animals. (1967) (193)
Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides (1995) (174)
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1997) (162)
Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. (1993) (157)
Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties (1980) (149)
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1994) (145)
Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. (1981) (140)
Enhancing T lymphocytes from tumor‐bearing mice suppress host resistance to a syngeneic tumor (1974) (133)
THE FORMATION OF HYBRID MULTINUCLEATED MUSCLE FIBERS FROM MYOBLASTS OF DIFFERENT GENETIC ORIGIN. (1965) (132)
Differences in cell surface antigens of tumor metastases and those of the local tumor. (1979) (124)
Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells. (1979) (117)
ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS. (1964) (109)
Defective induction of antigen‐reactive proliferating T cells in B cell‐deprived mice (1981) (107)
GROWTH OF A LOCAL TUMOR EXERTS A SPECIFIC INHIBITORY EFFECT ON PROGRESSION OF LUNG METASTASES (1978) (104)
Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cells (1993) (104)
THE EFFECT OF ACTINOMYCIN D ON HEART AND THIGH MUSCLE CELLS GROWN IN VITRO. (1964) (98)
MHC class I‐restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope (1999) (98)
Thymus-Derived Lymphocytes: Humoral and Cellular Reactions Distinguished by Hydrocortisone (1972) (95)
Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene. (1988) (94)
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. (2002) (93)
AUTOSENSITIZATION IN VITRO (1971) (92)
Graft reaction in tissue culture. II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on mouse embryo monolayers. (1969) (92)
Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells. (1978) (90)
Generation of invasive and metastatic variants of a non‐metastatic T‐cell lymphoma by in vivo fusion with normal host cells (1984) (73)
Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. (1981) (73)
Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro. (1975) (72)
H‐2Kb TRANSFECTION OF B16 MELANOMA CELLS RESULTS IN REDUCED TUMOURIGENICITY AND METASTATIC COMPETENCE (1989) (67)
Hepatosplenic γδ T-cell lymphoma : Ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation (1997) (67)
Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity. (1980) (66)
IN VITRO INDUCTION OF A PRIMARY RESPONSE TO THE DINITROPHENYL DETERMINANT (1970) (65)
Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus. (2001) (62)
Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction. (1970) (61)
Kinetic analysis of a graft reaction induced in cell culture. (1969) (60)
Sequential Enrichment and Immunocytochemical Visualization of Human Interferon-α-Producing Cells (1990) (56)
Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells. (1983) (55)
The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect. (1970) (54)
On the mechanism of tumor ‘concomitant immunity’ (1981) (51)
Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. (1982) (47)
Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties. (1983) (45)
Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. (1995) (45)
MANIPULATION OF METASTASIS AND TUMOUR GROWTH BY TRANSFECTION WITH HISTOCOMPATIBILITY CLASS I GENES (1986) (44)
Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens. (1976) (44)
Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells (2004) (44)
Proteolytic enzymes in tumor metastasis. II. Collagenase type IV activity in subcellular fractions of cloned tumor cell populations. (1985) (43)
Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report. (1996) (43)
The peritoneal antigen‐presenting macrophage: control and immunogenic properties of distinct subpopulations (1981) (42)
Specific Blocking in vitro of Antibody Synthesis by Affinity Labelling Reagents (1969) (41)
Suppressor factor secreted by T-lymphocytes from tumor-bearing mice. (1976) (41)
Novel breast‐tumor‐associated MUC1‐derived peptides: Characterization in Db−/− × β2 microglobulin (β2m) null mice transgenic for a chimeric HLA‐A2.1/Db‐β2 microglobulin single chain (2000) (41)
Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV) (1994) (41)
Immuno‐selection In vivo of H‐2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence (1984) (41)
ROLE OF THE THYMUS IN RESTORATION OF: IMMUNE REACTIVITY AND LYMPHOID REGENERATION IN IRRADIATED MICE (1964) (40)
INDUCTION OF T‐CELL DIFFERENTIATION IN VITRO BY THYMUS EPITHELIAL CELLS * (1975) (40)
REJECTION OF TUMOR ALLOGRAFTS BY MOUSE SPLEEN CELLS SENSITIZED IN VITRO (1971) (37)
Defective induction of antigen‐reactive proliferating T cells in B cell‐deprived mice II. Anti‐μ treatment affects the initiation and recruitment of T cells (1983) (37)
Transformation of thymocytes by thymus epithelium derived from AKR mice (1976) (37)
THE DEVELOPMENT OF HYPERSENSITIVE LYMPHOCYTES IN CELL CULTURE (1971) (36)
Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells. (1977) (36)
Effect of Concanavalin A on Lymphocyte-mediated Cytotoxicity (1971) (34)
IN VITRO INDUCTION OF A HETEROGRAFT REACTION: Immunological Parameters of the Sensitization of Rat Lymphocytes Against Mouse Cells in Vitro (1971) (33)
Normal T-cell receptors for alloantigens. (1973) (33)
In vitro activation of the in vivo colony‐forming units of the mouse yolk sac (1977) (33)
A bicellular mechanism in the immune response to chemically defined antigens. I. Antibody formation in vitro. (1971) (33)
Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes. (1993) (33)
Specific cytotoxicity in vitro of lymphocytes sensitized in culture against tumor cells. (1976) (32)
Cell Interactions in the Induction of Antibody Formation (1967) (32)
Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations. (1979) (31)
General anesthesia during excision of a mouse tumor accelerates postsurgical growth of metastases by suppression of natural killer cell activity. (1986) (30)
The mechanism of modulation of humoral immune responses after infection of mice with lactic dehydrogenase virus. (1982) (29)
A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation. (1976) (29)
Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma. (1985) (29)
Macrophage-hybridomas: generation, structure, and function. (1984) (29)
On the role of the thymus in recovery of immunological reactivity following x-irradiation. (1962) (29)
Enhancing lymphocytes in spleens of tumor‐bearing mice: affinity chromatography on insolubilized histamine (1977) (29)
Anti‐tumor immunity in b‐lymphocyte‐deprived mice. iii. immunity to primary moloney sarcoma virus‐induced tumors (1982) (29)
STUDIES ON THE COMPETENCE OF SINGLE CELLS TO PRODUCE ANTIBODIES OF TWO SPECIFICITIES (1968) (28)
Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. (1997) (28)
H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire. (1992) (28)
Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines. (1999) (28)
What makes a tumor cell metastatic? (1988) (28)
Immunotherapy of tumor metastasis via gene therapy. (1994) (27)
The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes. (1988) (27)
Selection of 3LL tumor subline resistant to natural effector cells concomitantly selected for increased metastatic potency (1982) (27)
Sex-associated differences in the immune response against fetal major histocompatibility antigens. (1981) (26)
Interferon‐α ‐dependent and ‐independent participation of accessory cells in natural killer cell‐mediated lysis of HSV‐1‐infected fibroblasts (1992) (26)
Immunization by gamma‐IFN‐treated B16‐F10.9 melanoma cells protects against metastatic spread of the parental tumor (1991) (25)
Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji. (1989) (25)
Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum (1978) (25)
Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes. (1989) (25)
T‐Cell Mediated Immunity in Vitro: an Analysis of Antigen Recognition and Target Cell Lysis (1972) (24)
A randomized, placebo-controlled, blind anti-AIDS clinical trial : safety and immunogenicity of a specific anti-IFNα immunization (1994) (24)
The effect of hydrocortisone on lymphocyte-mediated cytolysis. (1973) (24)
Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency. (1985) (23)
Human normal CTL clones: Generation and properties (1983) (23)
Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice. (1981) (23)
DETECTION OF INFECTIOUS HTLV-III/LAV VIRUS IN CELL-FREE PLASMA FROM AIDS PATIENTS (1985) (22)
Production of Clones of Lymphoid Cell Populations (1965) (22)
MHC class I genes controlling the metastatic phenotype of tumor cells. (1991) (22)
Receptor-mediated endocytosis of tuftsin by macrophage cells. (1984) (22)
DNA replication as a prerequisite for the induction of primary antibody response. (1972) (22)
Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells. (1995) (21)
Splenic B cells function as immunogenic antigenpresenting cells for the induction of effector T cells (1983) (21)
STIMULATION OF RAT LYMPHOCYTE PROLIFERATION BY HYDROCORTISONE DURING THE INDUCTION OF CELL-MEDIATED IMMUNITY IN VITRO (1974) (21)
Selecting, accelerating and suppressing interactions between macrophages and tumor cells. (1985) (21)
Lymphoid cells sensitized in vitro against allogeneic or syngeneic fibroblasts produce immune effects in vitro and in vivo. (1971) (21)
PROTECTION OF X‐IRRADIATED MICE BY “CLONED” HAEMOPOIETIC CELLS1 (1965) (21)
A bicellular mechanism in the immune response to chemically defined antigens. 3. Interaction of thymus and bone marrow-derived cells. (1971) (21)
Capacity of thymic cells to effect target cell lysis following treatment with concanavalin A. (1972) (20)
TRANSITION FROM T CELL PROTECTION TO T CELL ENHANCEMENT DURING TUMOR GROWTH IN AN ALLOGENEIC HOST (1976) (20)
Antibodies in Ribonucleoproteins (1960) (19)
Cytotoxic T-Lymphocyte Differentiation and Cytogenetic Alterations in γδ Hepatosplenic T-Cell Lymphoma and Posttransplant Lymphoproliferative Disorders (1997) (19)
IN VITRO GENERATION OF MEMORY LYMPHOCYTES REACTIVE TO TRANSPLANTATION ANTIGENS (1974) (19)
Genes controlling the metastatic phenotype. (1988) (19)
Mouse platelet-derived growth factor alpha receptor: sequence, tissue-specific expression and correlation with metastatic phenotype. (1992) (19)
Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy. (1993) (18)
THE ROLE OF THE THYMUS IN RESTORING IMMUNOLOGICAL REACTIVITY AND LYMPHOID CELL DIFFERENTIATION IN X‐IRRADIATED ADULT MICE * (1964) (18)
IN VIVO EFFECTS OF LYMPHOCYTES SENSITIZED IN VITRO AGAINST TUMOR CELLS * (1976) (18)
Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. (1982) (18)
Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine. (1978) (18)
The antibody response to successful tumor homografts. (1957) (17)
Immunogenetic control of metastasis formation by a methylcholanthrene-induced tumor (T10) in mice: differential expression of H-2 gene products. (1981) (17)
Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain. (2000) (17)
Specific Immunologic Unresponsiveness to Synthetic Polypeptide Antigens (1963) (17)
Antibody production by 'cloned' cell populations. (1966) (16)
Peripheral blood of AIDS patients contains cells capable of providing accessory function for the natural killer cell-mediated, lysis of herpes simplex virus-infected targets despite low interferon-alpha production. (1993) (16)
An immunoregulatory factor associated with spleen cells from tumor‐bearing animals. I. Effect on tumor growth and antibody production (1978) (16)
Thymus-derived lymphocytes control the expression of immunogenic properties of peritoneal macrophages. (1979) (16)
Graft reaction in tissue culture. 3. Effect of phytohaemagglutinin. (1969) (16)
Immunogenetic properties of tumors that have acquired homotransplantability. (1958) (16)
Induction of antitumor immunity by proteasome‐inhibited syngeneic fibroblasts pulsed with a modified TAA peptide (2000) (16)
c‐fos transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence (1990) (15)
Expression of major histocompatibility class I genes in differentiating leukemic cells is temporally related to activation of c-fos proto-oncogene. (1987) (15)
Studies on the mechanism of immunological enhancement of tumor grafts. (1960) (15)
Immune Reactivity of Lymphocytes (1976) (15)
Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine Interleukin 12 (1998) (15)
Expression of functionally intact pdgf‐α receptors in highly metastatic 3ll lewis lung carcinoma cells (1993) (15)
Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination. (1999) (14)
Combined therapy with IL‐6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomas (1993) (14)
Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? (1995) (14)
Production of Organ-Specific Antibodies following an Induction of Tolerance to Antigens of Heterologous Organs (1957) (14)
Lack of a T-cell dependent subpopulation of macrophages in (dichloromethylene) diphosphonate-treated mice. (1983) (14)
Immunological tolerance: high-dose antigen-induced suppressor cells from tolerant animals inactivate antigen-presenting macrophages. (1979) (14)
Immunobiological diversity of metastatic cells (1982) (14)
Primary cultures of human spleen macrophages in vitro. (1976) (14)
Immunogenic function of macrophages: in vitro production of antibodies to a hapten-carrier conjugate. (1972) (14)
A bicellular mechanism in the immune response to chemically defined antigens. II. Immunological tolerance. (1971) (14)
Effect of splenectomy on the progression of postoperative pulmonary metastases of the 3LL tumor. (1982) (14)
T-cell subset analysis of Lewis lung carcinoma tumor rejection: heterogeneity of effectors and evidence for negative regulatory lymphocytes correlating with metastasis. (1992) (14)
Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms. (1987) (13)
Immunogenetic studies on x-irradiated mice treated with homologous hematopoietic cells. (1958) (13)
Involvement of the spleen in the control of the immunogenic and phagocytic function of thioglycollate‐induced macrophages (1981) (13)
The use of [35S]methionine as a target cell label in long term cytotoxic assays. (1992) (13)
Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells (1997) (13)
In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. II. Characterization of two different effector activities and of suppressor cells. (1977) (12)
An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts. (1982) (12)
Cytotoxic antibodies in the homograft reaction. (1958) (12)
The antigen determined by a Y-linked histocompatibility gene. (1958) (12)
Macromolecular synthesis during the sensitization of rat lymphcytes on mouse fibroblasts in vitro. (1971) (12)
Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity. (1986) (11)
Sequential enrichment and immunocytochemical visualization of human interferon-alpha-producing cells. (1990) (11)
REGULATION OF INTRASPLENIC FORMATION OF ERYTHROID CLONES * (1966) (11)
Effect of lactic dehydrogenase virus infection on tumor induction and tumor growth. (1981) (11)
Tuftsin receptors. (1983) (10)
Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders. (1997) (10)
AN IN VITRO ASSAY OF CELL‐MEDIATED CYTOTOXICITY: Terminal Labeling with 3H‐Leucine (1976) (10)
Role of tyrosine kinases, protein kinase C, and protein kinase A in the regulation of interferon-alpha production induced by herpes simplex virus type 1. (1996) (10)
Phenotypic diversity within clones of human normal t cells (1983) (10)
FETAL BONE GRAFTS DO NOT ELICIT ALLOGRAFT REJECTION BECAUSE OF PROTECTING ANTI‐Ia ALLOANTIBODIES: IMPLICATIONS TO THE IMMUNE SURVIVAL OF FETUSES IN ALLOGENEIC MOTHERS (1979) (9)
In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. I. Primary sensitization of lymphocyte subpopulations. (1977) (9)
Studies on the nature of messenger RNA in phytohemagglutinin-stimulated rat lymphocytes. (1971) (9)
Heterogeneity of Human Natural Killer Cells (1985) (9)
PRENATAL IDENTIFICATION OF BLOOD-GROUP ANTIGENS (1956) (9)
Acquisition of Metastatic Properties via Somatic Cell Fusion: Implications for Tumor Progression in Vivo (1986) (9)
Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity. (1983) (9)
The induction of antibody production in x-irradiated animals by macrophages that interacted with antigen. (1966) (9)
Control of MHC genes that regulate the metastatic phenotype of tumor cells. (1988) (9)
Immunogenetic studies on x-irradiated mice treated with hematopoietic cells and grafted with tumor tissues. (1959) (8)
Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodies. (1996) (8)
DIFFERENTIAL IMMUNOGENIC EXPRESSION OF AN H‐2-LINKED HISTOCOMPATIBILITY ANTIGEN ON DIFFERENT TISSUES: DIFFERENCES IN SURVIVAL BETWEEN HEART, THYROID, AND SKIN ALLOGRAFTS1 (1979) (8)
Interactions between the local tumor and its metastases (2004) (8)
Tumor cell surface determinants in host immunity against metastases. (1991) (8)
The immunoregulatory characteristics of the lactic dehydrogenase virus (LDV), a common contaminant of tumors. (1981) (8)
Macrophage-mediated in vitro sensitization of T-lymphocytes. I; Detection of murine leukemia virus-associated antigens. (1977) (7)
The Function of Tuftsin and Similar Sequences in Other Proteins (1983) (7)
The reversal of the metastatic phenotype by gene transfer. (2007) (7)
IMMUNOLOGICAL PROPERTIES OF CHEMICALLY INDUCED SARCOMAS. (1963) (7)
GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO (1970) (7)
An immunoregulatory factor associated with spleen cells from tumor‐bearing animals. II. Characterization of the cell populations involved in its production and release (1978) (7)
Class I MHC antigens of different subregions induce different IgG subclasses. (1983) (7)
Genes and antigens controlling tumor metastases. (1985) (7)
Self recognition in the immune system. (1979) (6)
Mouse Cell Destruction by in vitro Sensitized Rat Lymphoid Cells (1971) (6)
An immunoregulatory factor associated with spleen cells from tumor‐bearing animals.: III. Characterization of the factor's target cells (1979) (6)
Organ-specific homing of B-cell hybridomas. (1982) (6)
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. (1994) (5)
Macrophage hybridomas: an approach to the analysis of the functional heterogeneity of macrophages. (1982) (5)
Immunogenetic changes induced in tumors grown in radiation chimeras. (1959) (5)
Interleukin‐6: Effects on Tumor Models in Mice and on the Cellular Regulation of Transcription Factor IRF‐1 a (1995) (5)
Graft reaction in cell culture. (1969) (5)
Macrophages, lymphocytes and antibody formation. (1969) (5)
In vitro sensitization of human lymphocytes against allogeneic cells by antigen-fed macrophages. (1979) (5)
Effect of treatment with the methanol extraction residue fraction of killed tubercle bacilli (MER) on the development of spontaneous pulmonary metastases from syngeneic implants of tumor 3LL in C57B1 mice. (1976) (5)
Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers. (1984) (5)
In vitro retrieval of the cytotoxic potential of spleen cells of tumor-bearing mice. (1978) (5)
Reception of immunogenic signals by lymphocytes. (1974) (4)
Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretion. (1988) (4)
Deficient interferon-alpha production but normal natural killer cell activity in an AIDS patient with HIV-2 infection. (1989) (4)
Macrophages: Their Role in the Induction of Immunity (1971) (4)
Tuftsin Binding to Various Macrophage Hybridomas a (1983) (4)
Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells (2004) (4)
Immunomodulation of Tumor Metastases (1986) (4)
Oligocellular mechanism in the production of antibodies: in vitro response to a haptenic determinant. (1973) (4)
Cellular Immunity in Vitro : Specific Antigen Induces Sensitization and Activates a Nonspecific Cytolytic Effect (1971) (4)
Genetic regulation of metastasis progression: the development of pulmonary metastases of the 3LL lung carcinoma is controlled by both a non-H-2 gene(s) and a gene(s) linked to the H-2D region of the mouse MHC. (1981) (4)
Retracted Correction: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1998) (3)
Host's immune state and kinetics of local tumor growth control--progression of postoperative lung metastasis. (1980) (3)
Oncogenes and Tyrosine Kinase Activities as a Function of the Metastatic Phenotype (1986) (3)
The Cellular Components in the Induction of Antibody by x-Irradiated Animals (1967) (3)
THE IMMUNOGENIC FUNCTION OF MACROPHAGES11This work was supported by Research Grant CA 06165 from the National Institutes of Health, United States Public Health Service, Bethesda, and a National Institutes of Health Agreement No. 335105. (1968) (3)
Generation of Metastatic Cells via Somatic Cell Fusion: A Possible Mechanism for Tumor Progression In-Vivo (1986) (3)
Immunogenetic control of metastatic competence of cloned tumor cell populations. (1983) (3)
Enrichment of suppressor cell activity by hydrocortisone: Suppression of in vitro activation of splenocytes from mice bearing lewis lung carcinoma (1980) (3)
Mediators of Cellular Immunity (1979) (3)
Cell Interactions in the In Vitro Production of Antibodies to Chemically Defined Antigens (1971) (3)
Nonorganophilic, hematogenous dissemination in the presence of positive lymph nodes of a malignant tumor in rabbits. (1984) (3)
Suppressor cells prevent host resistance to tumor growth (1979) (3)
Gene Products of the Major Histocompatibility Complex Control the Metastatic Phenotype of Tumor Cells (1986) (3)
Macrophage-mediated in vitro sensitization of lymphocytes. II. The detection of neo-antigens on transformed lymphocytes and passages of normal fibroblasts. (1978) (3)
CELLULAR INTERACTIONS CONTROLLING THE IMMUNE REACTIVITY OF T‐LYMPHOCYTES * (1975) (3)
Macrophage-mediated in vitro sensitization of lymphocytes (1978) (2)
THE GENERATION OF AN ALLOSPECIFIC SUPPRESSOR FACTOR IN CULTURE (1979) (2)
SEX‐ASSOCIATED DIFFERENCES IN THE IMMUNE RESPONSE AGAINST FETAL MAJOR HISTOCOMPATIBILITY ANTIGENS: II. Association Of The Female IgG1 With H‐2k‐Encoded Alloantigens (1983) (2)
Effect of an acute viral infection by a silent virus on the humoral immune responses. (1982) (2)
Heterogeneity of human natural killer cells. (1985) (2)
Do oncogenes play a role in tumor metastasis? (1988) (2)
In vivo activity of lymphocytes sensitized in vitro by antigen-fed macrophages: inhibition of lymphoma growth. (1979) (2)
H-2K region-controlled products of the murine major histocompatibility complex differ in their immunogenic capacity when expressed on different tissues. (1981) (2)
Immunogenetic Determinants Controlling the Metastatic Properties of Tumor Cells (1983) (2)
Tuftsin Receptors a (1983) (2)
IMMUNOGENETIC PROPERTIES OF TUMOR METASTASES11Supported by PHA grant No. 28139 awarded by the National Cancer Institute, Department of Human Health Services, Bethesda, Maryland, USA and by the Schilling Foundation, Essen, FRG. (1982) (2)
Involvement of peritoneal macrophages and spleen stromal cells in X-irradiation-induced reticulum cell neoplasms in C57BL/6 mice. (1982) (2)
Impairment of antigen-specific T cell proliferative response in B cell suppressed mice. (1982) (2)
Anesthetic Drugs Accelerate the Progression of Postoperative Metastases of Mouse Tumors (1982) (1)
Immunostimulation by an Ig derived tetrapeptide, tuftsin (1979) (1)
IMMUNE SURVEILLANCE AND FETO-MATERNAL RELATIONSHIPS: SUPPRESSION OF IMMUNE FUNCTIONS BY MOUSE AMNIOTIC FLUID (1979) (1)
BODY PAINS AND LOSS OF WEIGHT. (1963) (1)
Tumor-Associated Antigen Peptides as Anti-Metastatic Vaccines (2004) (1)
Cytopathogenic Mechanisms Which Lead to Cell Death of HTLV III Infected T Cells (1986) (1)
Immunological Tolerance and Host-Tumour Relationship (1967) (1)
Immunogenic capacity of macrophage hybridomas (1989) (1)
Immune reactivity of lymphocytes : development, expression, and control : [proceedings] (1976) (1)
T‐cell subset analysis of 3LL tumor growth (1991) (1)
THE PRENATAL DIAGNOSIS OF HUMAN ABNORMALITIES (1956) (1)
Elimination of endogenous xenotropic retroviruses from peritoneal macrophages in virus-induced T cell lymphoma. (1983) (1)
From Aristotle, through Spemann, to tumor immunology: a personal experience. (1995) (1)
Differential immunogenic expression of an h-2-linked histo- compatibility antigen on different tissues. (1979) (1)
Immunogenetics of Tumours Grown in Radiation Chimeras (2008) (1)
Immunogenetic Determinants of Metastatic Cells (1983) (1)
Selection of an immunogenic 3LL tumor subline following serial growth in vivo in the local presence of peritoneal macrophages. (1982) (1)
FUNCTION OF MACROPHAGES IN THE INDUCTION OF ANTIBODY PRODUCTION IN X- IRRADIATED ANIMALS. (1968) (1)
Human Natural Killer Cells Require an HLA-DR-Positive Accessory Cell to Mediate Lysis of HSV-1-Infected Human Fibroblasts (1989) (1)
Thymocyte maturation in AKR leukemia. (1976) (1)
MHC Control of Growth and Metastatic Properties of Tumor Cells (1993) (1)
Histone Deacetylase Inhibitors Promote the Ex Vivo Expansion of Cord Blood CD34+ Cells in Serum Free Cultures Accompanied by the Upregulation of Pluripotency Genes (2012) (1)
Immunogenetic changes induced in tumors grown in radiation chimeras. (1959) (1)
Cytotoxic and proliferative effect of tobacco products on Lewis lung adenocarcinoma cells and spleen lymphocytes. (1989) (0)
CXCR4 AND CCR5 EXPRESSION DURING HUMAN B-CELL DEVELOPMENT. (1998) (0)
Mechanism of tumor "concomitant immunity." Abstr. (1980) (0)
MACROPHAGES: INHIBITION OF LYMPHOMA GROWTH (1979) (0)
FEED-BACK REGULATION OF HAEMOPOIESIS. (1968) (0)
Tumor immunology and cytokines (2004) (0)
The development and implementation of a teaching unit on the immune system for secondary schools in Israel (1987) (0)
Accessory cell ac dependent natural killer cell lysis of hsv infected targets by aids patients occurs in the absence of interferon production (1991) (0)
Proceedings: in vitro destruction of 3LL tumor cells by syngeneic in vitro-sensitized lymphocytes. (1975) (0)
Studies on the Feedback Regulation of Haemopoiesis (2008) (0)
Inhibition of Tumor Allografts by Spleen Cells Sensitized In Vitro (0)
Immunogenetic studies on X-irradiated mice treated with hematopoietic cells and grafted with tumor tissues. (1959) (0)
CORRECTION (2006) (0)
Heterogeneity in the generation of cytotoxic t lymphocytes in vitro revealed by sensitivity to hydrocortisone. Abstr. (1976) (0)
Tumor-associated antigen peptides as anti-metastatic vaccines (1998) (0)
Specific Blocking of in vitro Antibody Response by Affinity Labeling Reagents (1970) (0)
ANTIGENIC DIFFERENCES EXIST BETWEEN CELL SURFACE ANTIGENS OF THE LOCAL TUMOR AND ITS METASTASES (1979) (0)
R E J E C T I O N OF TUMOR ALLOGRAFTS BY MOUSE SPLEEN CELLS (2003) (0)
Cytotoxic t-lymphocytes induced in vitro by antigen-fed macrophages. Abstr. (1976) (0)
Antigen‐induced feedback suppression: antigen‐specific initiator T cells fail to recruit new antigen‐reactive cells in immunized mice (1980) (0)
THE D EVELOPMENT OF HYPERSENSITIVE L YMPHOCYTES IN CELL CULTURE (1971) (0)
FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EF)~ECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION* (2004) (0)
Gene therapy and peptide therapy of tumor metastasis (2007) (0)
Involvement of the spleen in regulation of the immunogenic function of antigen presenting macrophages (1980) (0)
Differentiation and Immunological Competence of Cloned Cell Populations of Lymphoid Origin (2008) (0)
88. Antitumor effects of human IL-6 in murine leukemia and solid tumor models (1992) (0)
Immunological properties of chemically induced sarcomas. (1963) (0)
Mechanisms controlling differentiation and function of antigen-presenting macrophages. (1982) (0)
Amplification of the expression of major histocompatibility class-I antigens by inducers of differentiation and gamma interferon in murine and human solid tumor-cell lines. (1993) (0)
AUTOSENSITIZATIO N IN VITRO (2004) (0)
Late abstracts 186–187 (2005) (0)
Metastatic properties of b cell hybridomas (1981) (0)
Immunotherapy of tumor metastases by in vitro sensitized lymphocytes. (1975) (0)
RECEPTORS FOR TUFTSIN ON PLASMA MEMBRANES OF MACROPHAGES AND MACROPHAGE HYBRIDOMA CELL LINES (1987) (0)
Anti-Tumor Vaccination in Heterozygous Congenic F1 Mice: Presentation of Tumor-Associated Antigen by the Two Parental Class I Alleles (2000) (0)
IMMUNOSUPPRESSOR CELLS IN THE REGULATION OF THE ANTITUMOR IMMUNE RESPONSE (1979) (0)
Tuftsin Analogues: Synthesis, Structure-Function Relationships, and Im- plications for Specificity of Tuftsin′s Bioactivity. (1987) (0)
CONTROL OF MACROPHAGE-T CELL INTERACTIONS (1980) (0)
In vitro reactivation of antibody response in explants of irradiated spleens. Lymphatic tissue and germinal centers in immune response, plenum, (1969) (0)
The Immunogenetics of MHC Controlled Antigenic Determinants on Lewis-Lung-Carcinoma (3LL) Cells (1983) (0)
The control of tumor metastasis. (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael J. Feldman?

Michael J. Feldman is affiliated with the following schools:

Michael J. Feldman's Academic­Influence.com Rankings

Why Is Michael J. Feldman Influential?

Michael J. Feldman's Published Works

Published Works

What Schools Are Affiliated With Michael J. Feldman?

Michael J. Feldman's AcademicInfluence.com Rankings